Home Page ::: CNS & Neurological Disorders - Drug Targets

ISSN: 1996-3181 (Online)
ISSN: 1871-5273 (Print)

Volume 15, 10 Issues, 2016

Download PDF Flyer


CNS & Neurological Disorders - Drug Targets

Formerly: Current Drug Targets - CNS & Neurological Disorders

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online


Stephen D. Skaper

Department of Pharmaceutical and Pharmacological Sciences
University of Padova

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.188
5 - Year: 2.599
Browse Contents
Select Volume:

Select Issue:

Select Article:

Abstracted/Indexed in


"This journal is the definitive source for the most meaningful and critical information available on CNS drug targets and progress both in industrial and academic based neurodegeneration research."

Rudolf E. Tanzi
Harvard Medical School, USA

Forthcoming Special Issue(s)

Current Perspective on Anti-Neurodegenerative Disorder’s Investigation: Computational Approaches to Clinical Research

Guest Editor(s): Anurag Khatkar
Tentative Publication Date: February, 2018
Submit Abstract via Email Download Description
Special Issue(s) - In-Press

Brain Imaging and Automatic Analysis in Neurological and Psychiatric diseases

Guest Editor(s): Yu-Dong Zhang, Ti-Fei Yuan, Zheng-Chao Dong
Submit Abstract via Email
Published Special Issue(s)

Editorial Advisory Board Members Special Issue

Guest Editor(s): Stephen D. Skaper

Authors' Comments
I am extremely grateful for working with Bentham Science. In my opinion, it is one of the best publishers.

Gjumrakch Aliev, MD & PhD
(President "GALLY" International Biomedical Research Consulting LLC, San Antonio, TX, USA)

Has contributed: Neuroprotective effects of the securinine-analogues: identification of Allomargaritarine as a lead compound

CNS & Neurological Disorders - Drug Targets


Volume 15


Number 10


Related Journals

Related eBooks

Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science